Bladder Leiomyosarcoma following Cyclophosphamide Therapy for Breast Cancer

Publisher： Karger

E-ISSN： 1661-7657|2|1|48-50

ISSN： 1661-7649

Source： Current Urology, Vol.2, Iss.1, 2008-08, pp. : 48-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intensified Adjuvant Cyclophosphamide, Methotrexate and 5-Fluorouracil Therapy: A Dose-Finding Study for Ambulatory Patients with Breast Cancer

By  

Oncology, Vol. 56, Iss. 2, 1999-02 ,pp. : 103-109

Karger

Access to resources Recommend Favorite

Global abnormalities in lymphatic function following systemic therapy in patients with breast cancer

By  

BRITISH JOURNAL OF SURGERY, Vol. 102, Iss. 5, 2015-04 ,pp. : 534-540

John Wiley & Sons Inc

Access to resources Recommend Favorite

Leiomyosarcoma of the Bladder in a Retinoblastoma Patient

By  

Urologia Internationalis, Vol. 71, Iss. 1, 2003-07 ,pp. : 118-121

Karger

Access to resources Recommend Favorite

Doxorubicin and Paclitaxel versus Fluorouracil, Doxorubicin and Cyclophosphamide as First-Line Therapy for Women with Advanced Breast Cancer: Long-Term Analysis of the Previously Published Trial

By  

Oncology Research and Treatment, Vol. 32, Iss. 8-9, 2009-07 ,pp. : 468-472

Karger

Access to resources Recommend Favorite

Isolated Renal Tuberculosis following Intravesical Bacillus Calmette-Guérin Therapy for Bladder Cancer

By  

Urologia Internationalis, Vol. 72, Iss. 3, 2004-04 ,pp. : 257-260

Karger

Access to resources Recommend Favorite